Everest Biotech specializes in the development and production of high-quality antibodies, particularly anti-peptide and antigen affinity purified goat polyclonal antibodies. Since its inception in 2000, the company has maintained a strong commitment to quality, which is underscored by its ISO 9001:2015 accreditation. Their product offerings include both traditional polyclonal antibodies and recombinant monoclonal antibodies, which are essential for various scientific applications. The polyclonal antibodies are noted for their high affinity and sensitivity to different epitopes within the same sample, providing a cost-effective solution for target antigen detection. Each antibody undergoes rigorous testing by a team of quality control scientists to ensure batch consistency and value for money.

In addition to their core antibody products, Everest Biotech offers a range of related items, including immunizing peptides and secondary antibodies, which enhance the functionality of their primary antibodies in various applications such as immunofluorescence, flow cytometry, and immunohistochemistry. Their featured products, like the Goat Anti-AIF1/IBA1 (isoform 3) antibody, demonstrate the company's focus on providing specific and effective tools for researchers. The antibodies are designed to recognize specific protein isoforms and are validated for use in multiple species, ensuring broad applicability in scientific research. Overall, Everest Biotech's dedication to innovation and quality positions it as a valuable resource for researchers in the field of antibody-based applications.

United States

Everest Biotech discovers, develops and commercializes anti-peptide and goat
polyclonal antibodies for the biomedical industry.

Everest Biotech

Company Details